ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ACRV Acrivon Therapeutics Inc

7.35
0.19 (2.65%)
27 Nov 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -9.58M-9.95M-14.39M-15.52M-16.14M-21.05M-17.67M-21.44M
Pre Tax Income -9.2M-8.93M-12.76M-13.91M-14.47M-19.25M-16.49M-18.8M
Net Income -9.2M-8.93M-12.76M-13.91M-14.47M-19.25M-16.49M-18.8M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -9.2M-8.93M-12.76M-13.91M-14.47M-21.44M-17.93M-21.49M
EBITDA -9.46M-9.82M-14.27M-15.39M-16M-20.9M-17.44M-21.21M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 000
Operating Income -16.18M-32.66M-67.1M
Pre Tax Income -16.24M-31.17M-60.39M
Net Income -16.24M-31.17M-60.39M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -0.51-0.462-1.216
EBIT -16.18M-31.17M-67.49M
EBITDA -16.15M-32.29M-66.57M

Your Recent History

Delayed Upgrade Clock